These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14988706)

  • 21. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
    J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desmoplastic melanoma: a heterogeneous entity in which subclassification as "pure" or "mixed" may have important prognostic significance.
    Scolyer RA; Thompson JF
    Ann Surg Oncol; 2005 Mar; 12(3):197-9. PubMed ID: 15827808
    [No Abstract]   [Full Text] [Related]  

  • 23. Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients.
    Satzger I; Völker B; Al Ghazal M; Meier A; Kapp A; Gutzmer R
    Histopathology; 2007 May; 50(6):764-72. PubMed ID: 17493240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Hartgrink HH; Van de Velde CJ
    Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1311-2; author reply 1312. PubMed ID: 15279220
    [No Abstract]   [Full Text] [Related]  

  • 25. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
    van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
    Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
    Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
    Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node.
    Pearl RA; Pacifico MD; Richman PI; Stott DJ; Wilson GD; Grobbelaar AO
    J Exp Clin Cancer Res; 2007 Mar; 26(1):109-15. PubMed ID: 17550139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognostic value of structural-functional characteristics of skin melanoma].
    Egorov MV; Konkina EA; Polishchuk RS
    Arkh Patol; 2005; 67(1):36-9. PubMed ID: 15822793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The significance of melanoma micrometastases in the sentinel lymph node.
    Giblin AV; Hayes AJ; Thomas JM
    Eur J Surg Oncol; 2005 Dec; 31(10):1103-4. PubMed ID: 16084052
    [No Abstract]   [Full Text] [Related]  

  • 31. Melanoma prognostic factors found in the dermatopathology report.
    Payette MJ; Katz M; Grant-Kels JM
    Clin Dermatol; 2009; 27(1):53-74. PubMed ID: 19095154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy.
    Yee VS; Thompson JF; McKinnon JG; Scolyer RA; Li LX; McCarthy WH; O'Brien CJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Uren RF
    Ann Surg Oncol; 2005 Jun; 12(6):429-39. PubMed ID: 15886905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.
    McHugh JB; Su L; Griffith KA; Schwartz JL; Wong SL; Cimmino V; Chang AE; Johnson TM; Sabel MS
    Ann Surg Oncol; 2006 Sep; 13(9):1216-23. PubMed ID: 16952026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.
    Winnepenninckx V; van den Oord JJ
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unusual histological variants of cutaneous malignant melanoma with some clinical and possible prognostic correlations.
    Rongioletti F; Smoller BR
    J Cutan Pathol; 2005 Oct; 32(9):589-603. PubMed ID: 16176296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of sentinel lymph node biopsy in patients with thin melanoma.
    Wong SL; Brady MS; Busam KJ; Coit DG
    Ann Surg Oncol; 2006 Mar; 13(3):302-9. PubMed ID: 16485151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma.
    Murali R; Hughes MT; Fitzgerald P; Thompson JF; Scolyer RA
    Ann Surg; 2009 Apr; 249(4):641-7. PubMed ID: 19300224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor thickness as a prognostic guide to melanoma.
    Macht SD
    Ann Surg; 1981 Jan; 193(1):121. PubMed ID: 7458444
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic significance of detecting micrometastases by tyrosinase RT/PCR in sentinel lymph node biopsies: lessons from 322 consecutive melanoma patients.
    Ulrich J; Bonnekoh B; Böckelmann R; Schön M; Schön MP; Steinke R; Roessner A; Schmidt U; Gollnick H
    Eur J Cancer; 2004 Dec; 40(18):2812-9. PubMed ID: 15571965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of sentinel node biopsy in patients with cutaneous melanoma.
    Aldredge LM
    Nurs Clin North Am; 2007 Sep; 42(3):379-92, v-vi. PubMed ID: 17825660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.